瑞思迈 RMD 深 沪
已收盘 05-22 16:00:00 美东时间
208.05
-0.930
-0.45%
华盛通- 最 高211.06
- 今 开208.98
- 成交量 109.57万股
- 最 低 207.251
- 昨 收 208.98
- 总市值 301.79亿
- 52周最高 292.01
- 市盈率 静 21.88
- 换手率 0.76%
- 52周最低 198.01
- 委 比 -80.18%
- 总股本 1.45亿
- 历史最高 292.01
- 量 比 0.81
- 振 幅 1.82%
- 历史最低 4.13
- 每 手 1
- 风险率 20.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apnimed's sleep apnea pill meets main goal in late-stage study
Apnimed's sleep apnea pill meets main goal in late-stage study May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative to device-based treatments. Here are
05-18 22:06
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that disappoint Wall Street.
05-12 19:00
ResMed CEO Michael Farrell disposes 4,991 shares for $1.04 million
ResMed CEO Michael Farrell disposes 4,991 shares for $1.04 million ResMed Chairman and CEO Michael J. Farrell sold 4,991 shares on May 7 at weighted average price USD 207.82. Sale followed exercise of 4,991 stock options at USD 146.34, leaving direct holdings at 466,223 shares. Form 4 also listed 2,
05-11 19:34
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
Out of 22 S&P 500 healthcare companies that reported results this week, 19 beat earnings expectations and 15 posted year-over-year EPS growth. All 22 companies recorded year-over-year revenue increase...
05-03 01:40
ResMed declares $0.60 dividend
ResMed (RMD) declares $0.60/share quarterly dividend, in line with previous. Forward yield 1.17% Payable June 18; for shareholders of record May 14; ex-div May 14. See RMD Dividend Scorecard, Yield Ch...
05-01 22:38
财报速睇 | 瑞思迈 2026财年Q1营收14.31亿美元，同比增长10.8%；归母净利润3.99亿美元，同比增长9.3%
华盛资讯5月1日讯，瑞思迈公布2026财年Q1业绩，公司Q1营收14.31亿美元，同比增长10.8%，归母净利润3.99亿美元，同比增长9.3%。
05-01 22:21
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Caterpillar, Textron and Wesco International, on Friday. HIGHLIGHTS * Arrowhead Pharmaceuticals ARWR.
05-01 15:29
财报速睇 | 瑞思迈 2026财年Q1营收14.31亿美元，同比增长10.8%；归母净利润3.99亿美元，同比增长9.2%
华盛资讯5月1日讯，瑞思迈公布2026财年Q1业绩，公司Q1营收14.31亿美元，同比增长10.8%，归母净利润3.99亿美元，同比增长9.2%。
05-01 07:56
Transcript: ResMed Q3 2026 Earnings Conference Call
ResMed (NYSE:RMD) released third-quarter financial results and hosted an earnin...
05-01 05:53
